The full dataset viewer is not available (click to read why). Only showing a preview of the rows.
Error code: FileSystemError
Need help to make the dataset viewer work? Make sure to review how to configure the dataset viewer, and open a discussion for direct support.
sample_id string | split string | compound_id string | smiles string | inchi string | inchikey string | primary_moa string | valid_moas list | benchmark_label string | benchmark_valid_labels list | is_novel bool |
|---|---|---|---|---|---|---|---|---|---|---|
ME_TEST_0001 | test | JCP2022_000088 | C#Cc1cccc(N=c2[nH]cnc3cc(OCCOC)c(OCCOC)cc23)c1 | InChI=1S/C22H23N3O4/c1-4-16-6-5-7-17(12-16)25-22-18-13-20(28-10-8-26-2)21(29-11-9-27-3)14-19(18)23-15-24-22/h1,5-7,12-15H,8-11H2,2-3H3,(H,23,24,25) | AAKJLRGGTJKAMG-UHFFFAOYSA-N | EGFR inhibitor | [
"EGFR inhibitor"
] | EGFR inhibitor | [
"EGFR inhibitor"
] | false |
ME_TEST_0002 | test | JCP2022_000405 | CCOCCn1c(C2CCN(CCc3ccc(C(C)(C)C(=O)O)cc3)CC2)nc2ccccc21 | InChI=1S/C28H37N3O3/c1-4-34-20-19-31-25-8-6-5-7-24(25)29-26(31)22-14-17-30(18-15-22)16-13-21-9-11-23(12-10-21)28(2,3)27(32)33/h5-12,22H,4,13-20H2,1-3H3,(H,32,33) | ACCMWZWAEFYUGZ-UHFFFAOYSA-N | histamine receptor antagonist | [
"histamine receptor antagonist"
] | histamine receptor antagonist | [
"histamine receptor antagonist"
] | false |
ME_TEST_0003 | test | JCP2022_000971 | CC(=O)NCCCS(=O)(=O)O | InChI=1S/C5H11NO4S/c1-5(7)6-3-2-4-11(8,9)10/h2-4H2,1H3,(H,6,7)(H,8,9,10) | AFCGFAGUEYAMAO-UHFFFAOYSA-N | glutamate receptor antagonist | [
"glutamate receptor antagonist"
] | glutamate receptor antagonist | [
"glutamate receptor antagonist"
] | false |
ME_TEST_0004 | test | JCP2022_001854 | COc1ccc(Cn2ccc3ccc(C(O)=NO)cc32)cc1 | InChI=1S/C17H16N2O3/c1-22-15-6-2-12(3-7-15)11-19-9-8-13-4-5-14(10-16(13)19)17(20)18-21/h2-10,21H,11H2,1H3,(H,18,20) | AJRGHIGYPXNABY-UHFFFAOYSA-N | HDAC inhibitor | [
"HDAC inhibitor"
] | HDAC inhibitor | [
"HDAC inhibitor"
] | false |
ME_TEST_0005 | test | JCP2022_002325 | CCCCc1nc(C)c(CC(=S)N(C)C)c(=O)n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1 | InChI=1S/C27H31N7OS/c1-5-6-11-24-28-18(2)23(16-25(36)33(3)4)27(35)34(24)17-19-12-14-20(15-13-19)21-9-7-8-10-22(21)26-29-31-32-30-26/h7-10,12-15H,5-6,11,16-17H2,1-4H3,(H,29,30,31,32) | AMEROGPZOLAFBN-UHFFFAOYSA-N | angiotensin receptor antagonist | [
"angiotensin receptor antagonist"
] | angiotensin receptor antagonist | [
"angiotensin receptor antagonist"
] | false |
ME_TEST_0006 | test | JCP2022_002559 | CS(=O)(=O)Nc1cc2occ(NC=O)c(=O)c2cc1Oc1ccccc1 | InChI=1S/C17H14N2O6S/c1-26(22,23)19-13-8-15-12(17(21)14(9-24-15)18-10-20)7-16(13)25-11-5-3-2-4-6-11/h2-10,19H,1H3,(H,18,20) | ANMATWQYLIFGOK-UHFFFAOYSA-N | cyclooxygenase inhibitor | [
"cyclooxygenase inhibitor",
"NFkB pathway inhibitor"
] | cyclooxygenase inhibitor | [
"cyclooxygenase inhibitor",
"NFkB pathway inhibitor"
] | false |
ME_TEST_0007 | test | JCP2022_002918 | CC(C)Cn1c(=O)n(C)c(=O)c2[nH]cnc21 | InChI=1S/C10H14N4O2/c1-6(2)4-14-8-7(11-5-12-8)9(15)13(3)10(14)16/h5-6H,4H2,1-3H3,(H,11,12) | APIXJSLKIYYUKG-UHFFFAOYSA-N | phosphodiesterase inhibitor | [
"phosphodiesterase inhibitor"
] | phosphodiesterase inhibitor | [
"phosphodiesterase inhibitor"
] | false |
ME_TEST_0008 | test | JCP2022_003111 | CC(C)NCC(O)COc1cccc2ccccc12 | InChI=1S/C16H21NO2/c1-12(2)17-10-14(18)11-19-16-9-5-7-13-6-3-4-8-15(13)16/h3-9,12,14,17-18H,10-11H2,1-2H3 | AQHHHDLHHXJYJD-UHFFFAOYSA-N | adrenergic receptor antagonist | [
"adrenergic receptor antagonist"
] | adrenergic receptor antagonist | [
"adrenergic receptor antagonist"
] | false |
ME_TEST_0009 | test | JCP2022_003677 | N=c1nc(-c2cc(Cl)ccc2Cl)[nH]c(=N)[nH]1 | InChI=1S/C9H7Cl2N5/c10-4-1-2-6(11)5(3-4)7-14-8(12)16-9(13)15-7/h1-3H,(H4,12,13,14,15,16) | ATCGGEJZONJOCL-UHFFFAOYSA-N | phosphodiesterase inhibitor | [
"phosphodiesterase inhibitor"
] | phosphodiesterase inhibitor | [
"phosphodiesterase inhibitor"
] | false |
ME_TEST_0010 | test | JCP2022_003711 | N=c1[nH]c(-n2cccn2)nc(-n2cccn2)c1Br | InChI=1S/C10H8BrN7/c11-7-8(12)15-10(18-6-2-4-14-18)16-9(7)17-5-1-3-13-17/h1-6H,(H2,12,15,16) | ATFXVNUWQOXRRU-UHFFFAOYSA-N | adenosine receptor antagonist | [
"adenosine receptor antagonist"
] | adenosine receptor antagonist | [
"adenosine receptor antagonist"
] | false |
ME_TEST_0011 | test | JCP2022_004754 | COc1ccccc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1 | InChI=1S/C22H31N3O3/c1-28-19-7-3-2-6-18(19)24-13-10-23(11-14-24)12-15-25-20(26)16-22(17-21(25)27)8-4-5-9-22/h2-3,6-7H,4-5,8-17H2,1H3 | AYYCFGDXLUPJAQ-UHFFFAOYSA-N | adrenergic receptor antagonist | [
"adrenergic receptor antagonist",
"serotonin receptor antagonist"
] | adrenergic receptor antagonist | [
"adrenergic receptor antagonist",
"serotonin receptor antagonist"
] | false |
ME_TEST_0012 | test | JCP2022_005029 | CNC(=O)c1c(C)oc2cc(Oc3ncnc4cc(OC)c(OC)cc34)ccc12 | InChI=1S/C21H19N3O5/c1-11-19(20(25)22-2)13-6-5-12(7-16(13)28-11)29-21-14-8-17(26-3)18(27-4)9-15(14)23-10-24-21/h5-10H,1-4H3,(H,22,25) | BALLNEJQLSTPIO-UHFFFAOYSA-N | VEGFR inhibitor | [
"VEGFR inhibitor"
] | VEGFR inhibitor | [
"VEGFR inhibitor"
] | false |
ME_TEST_0013 | test | JCP2022_005056 | CNCCn1c(=O)c2cc(OC)c(OC)cc2c2cnc3cc4c(cc3c21)OCO4 | InChI=1S/C22H21N3O5/c1-23-4-5-25-21-14-8-19-20(30-11-29-19)9-16(14)24-10-15(21)12-6-17(27-2)18(28-3)7-13(12)22(25)26/h6-10,23H,4-5,11H2,1-3H3 | BAORCAMWLWRZQG-UHFFFAOYSA-N | topoisomerase inhibitor | [
"topoisomerase inhibitor"
] | topoisomerase inhibitor | [
"topoisomerase inhibitor"
] | false |
ME_TEST_0014 | test | JCP2022_005373 | CS(=O)(=O)CCNCc1ccc(-c2ccc3[nH]cnc(=Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1 | InChI=1S/C29H26ClFN4O4S/c1-40(36,37)12-11-32-16-23-7-10-27(39-23)20-5-8-26-24(14-20)29(34-18-33-26)35-22-6-9-28(25(30)15-22)38-17-19-3-2-4-21(31)13-19/h2-10,13-15,18,32H,11-12,16-17H2,1H3,(H,33,34,35) | BCFGMOOMADDAQU-UHFFFAOYSA-N | EGFR inhibitor | [
"EGFR inhibitor"
] | EGFR inhibitor | [
"EGFR inhibitor"
] | false |
ME_TEST_0015 | test | JCP2022_005854 | Cc1nc(-c2cn3c(n2)-c2ccc(-c4cnn(C(C)(C)C(N)=O)c4)cc2OCC3)n(C(C)C)n1 | InChI=1S/C24H28N8O2/c1-14(2)32-22(27-15(3)29-32)19-13-30-8-9-34-20-10-16(6-7-18(20)21(30)28-19)17-11-26-31(12-17)24(4,5)23(25)33/h6-7,10-14H,8-9H2,1-5H3,(H2,25,33) | BEUQXVWXFDOSAQ-UHFFFAOYSA-N | PI3K inhibitor | [
"PI3K inhibitor"
] | PI3K inhibitor | [
"PI3K inhibitor"
] | false |
ME_TEST_0016 | test | JCP2022_006032 | C=CC(=O)Nc1cccc(N=c2[nH]c(=Nc3ccc(NC4CN(CCF)C4)cc3OC)[nH]cc2C(F)(F)F)c1 | InChI=1S/C26H27F4N7O2/c1-3-23(38)33-16-5-4-6-17(11-16)34-24-20(26(28,29)30)13-31-25(36-24)35-21-8-7-18(12-22(21)39-2)32-19-14-37(15-19)10-9-27/h3-8,11-13,19,32H,1,9-10,14-15H2,2H3,(H,33,38)(H2,31,34,35,36) | BFSRTTWIPACGMI-UHFFFAOYSA-N | EGFR inhibitor | [
"EGFR inhibitor"
] | EGFR inhibitor | [
"EGFR inhibitor"
] | false |
ME_TEST_0017 | test | JCP2022_006868 | COc1cc2c(cc1OCCCN1CCCC1)N=C(N)C21CCC1 | InChI=1S/C19H27N3O2/c1-23-16-12-14-15(21-18(20)19(14)6-4-7-19)13-17(16)24-11-5-10-22-8-2-3-9-22/h12-13H,2-11H2,1H3,(H2,20,21) | BKCDJTRMYWSXMC-UHFFFAOYSA-N | histone lysine methyltransferase inhibitor | [
"histone lysine methyltransferase inhibitor"
] | histone lysine methyltransferase inhibitor | [
"histone lysine methyltransferase inhibitor"
] | false |
ME_TEST_0018 | test | JCP2022_007067 | CCOC(=O)c1ccc(N)cc1 | InChI=1S/C9H11NO2/c1-2-12-9(11)7-3-5-8(10)6-4-7/h3-6H,2,10H2,1H3 | BLFLLBZGZJTVJG-UHFFFAOYSA-N | sodium channel blocker | [
"sodium channel blocker"
] | sodium channel blocker | [
"sodium channel blocker"
] | false |
ME_TEST_0019 | test | JCP2022_007081 | N=c1[nH]c2cc(-c3ccc4ncc(C(=O)N5CCOCC5)n4c3)ccc2o1 | InChI=1S/C19H17N5O3/c20-19-22-14-9-12(1-3-16(14)27-19)13-2-4-17-21-10-15(24(17)11-13)18(25)23-5-7-26-8-6-23/h1-4,9-11H,5-8H2,(H2,20,22) | BLGWHBSBBJNKJO-UHFFFAOYSA-N | PI3K inhibitor | [
"PI3K inhibitor"
] | PI3K inhibitor | [
"PI3K inhibitor"
] | false |
ME_TEST_0020 | test | JCP2022_007196 | COc1ccc2cc(CCC(C)=O)ccc2c1 | InChI=1S/C15H16O2/c1-11(16)3-4-12-5-6-14-10-15(17-2)8-7-13(14)9-12/h5-10H,3-4H2,1-2H3 | BLXXJMDCKKHMKV-UHFFFAOYSA-N | cyclooxygenase inhibitor | [
"cyclooxygenase inhibitor"
] | cyclooxygenase inhibitor | [
"cyclooxygenase inhibitor"
] | false |
ME_TEST_0021 | test | JCP2022_007295 | COc1ccc(-c2ccc3ncc4c(c3c2)n(-c2ccc(N3CCNCC3)c(C(F)(F)F)c2)c(=O)n4C)cn1 | InChI=1S/C28H25F3N6O2/c1-35-24-16-33-22-6-3-17(18-4-8-25(39-2)34-15-18)13-20(22)26(24)37(27(35)38)19-5-7-23(21(14-19)28(29,30)31)36-11-9-32-10-12-36/h3-8,13-16,32H,9-12H2,1-2H3 | BMMXYEBLEBULND-UHFFFAOYSA-N | PI3K inhibitor | [
"PI3K inhibitor"
] | PI3K inhibitor | [
"PI3K inhibitor"
] | false |
ME_TEST_0022 | test | JCP2022_007501 | CC(=O)NCCCCCCNC(C)=O | InChI=1S/C10H20N2O2/c1-9(13)11-7-5-3-4-6-8-12-10(2)14/h3-8H2,1-2H3,(H,11,13)(H,12,14) | BNQSTAOJRULKNX-UHFFFAOYSA-N | AKT inhibitor | [
"AKT inhibitor",
"differentiation inducer",
"NFKB pathway inhibitor"
] | AKT inhibitor | [
"AKT inhibitor"
] | false |
ME_TEST_0023 | test | JCP2022_007783 | CN1CCN(c2c(F)cc3c(=O)c(C(=O)O)cn4c3c2OCN4C)CC1 | InChI=1S/C17H19FN4O4/c1-19-3-5-21(6-4-19)14-12(18)7-10-13-16(14)26-9-20(2)22(13)8-11(15(10)23)17(24)25/h7-8H,3-6,9H2,1-2H3,(H,24,25) | BPFYOAJNDMUVBL-UHFFFAOYSA-N | bacterial DNA gyrase inhibitor | [
"bacterial DNA gyrase inhibitor"
] | bacterial DNA gyrase inhibitor | [
"bacterial DNA gyrase inhibitor"
] | false |
ME_TEST_0024 | test | JCP2022_007801 | Cc1cccc(C)c1N=C1NCCCS1 | InChI=1S/C12H16N2S/c1-9-5-3-6-10(2)11(9)14-12-13-7-4-8-15-12/h3,5-6H,4,7-8H2,1-2H3,(H,13,14) | BPICBUSOMSTKRF-UHFFFAOYSA-N | adrenergic receptor agonist | [
"adrenergic receptor agonist"
] | adrenergic receptor agonist | [
"adrenergic receptor agonist"
] | false |
ME_TEST_0025 | test | JCP2022_008514 | CC(=O)c1ccc2c(c1)N(CCCN1CCC(CCO)CC1)c1ccccc1S2 | InChI=1S/C24H30N2O2S/c1-18(28)20-7-8-24-22(17-20)26(21-5-2-3-6-23(21)29-24)13-4-12-25-14-9-19(10-15-25)11-16-27/h2-3,5-8,17,19,27H,4,9-16H2,1H3 | BTFMCMVEUCGQDX-UHFFFAOYSA-N | dopamine receptor antagonist | [
"dopamine receptor antagonist"
] | dopamine receptor antagonist | [
"dopamine receptor antagonist"
] | false |
ME_TEST_0026 | test | JCP2022_008838 | Cc1c(C#N)cccc1-c1cc(-c2cn(Cc3cccc(C(C)(C)O)n3)nn2)[nH]c(=N)n1 | InChI=1S/C23H22N8O/c1-14-15(11-24)6-4-8-17(14)18-10-19(28-22(25)27-18)20-13-31(30-29-20)12-16-7-5-9-21(26-16)23(2,3)32/h4-10,13,32H,12H2,1-3H3,(H2,25,27,28) | BUXIAWLTBSXYSW-UHFFFAOYSA-N | adenosine receptor antagonist | [
"adenosine receptor antagonist"
] | adenosine receptor antagonist | [
"adenosine receptor antagonist"
] | false |
ME_TEST_0027 | test | JCP2022_008964 | CCCCNNC(=O)c1ccc(Br)cc1 | InChI=1S/C11H15BrN2O/c1-2-3-8-13-14-11(15)9-4-6-10(12)7-5-9/h4-7,13H,2-3,8H2,1H3,(H,14,15) | BVQCFCYPFJOOAV-UHFFFAOYSA-N | HDAC inhibitor | [
"HDAC inhibitor"
] | HDAC inhibitor | [
"HDAC inhibitor"
] | false |
ME_TEST_0028 | test | JCP2022_009448 | O=C(O)COc1nn(Cc2ccccc2)c2ccccc12 | InChI=1S/C16H14N2O3/c19-15(20)11-21-16-13-8-4-5-9-14(13)18(17-16)10-12-6-2-1-3-7-12/h1-9H,10-11H2,(H,19,20) | BYFMCKSPFYVMOU-UHFFFAOYSA-N | cyclooxygenase inhibitor | [
"cyclooxygenase inhibitor"
] | cyclooxygenase inhibitor | [
"cyclooxygenase inhibitor"
] | false |
ME_TEST_0029 | test | JCP2022_009633 | CCCCOc1ccc(C(=O)CCN2CCCCC2)cc1 | InChI=1S/C18H27NO2/c1-2-3-15-21-17-9-7-16(8-10-17)18(20)11-14-19-12-5-4-6-13-19/h7-10H,2-6,11-15H2,1H3 | BZEWSEKUUPWQDQ-UHFFFAOYSA-N | sodium channel blocker | [
"sodium channel blocker"
] | sodium channel blocker | [
"sodium channel blocker"
] | false |
ME_TEST_0030 | test | JCP2022_009677 | CC(=O)N=c1[nH]nc(S(N)(=O)=O)s1 | InChI=1S/C4H6N4O3S2/c1-2(9)6-3-7-8-4(12-3)13(5,10)11/h1H3,(H2,5,10,11)(H,6,7,9) | BZKPWHYZMXOIDC-UHFFFAOYSA-N | carbonic anhydrase inhibitor | [
"carbonic anhydrase inhibitor"
] | carbonic anhydrase inhibitor | [
"carbonic anhydrase inhibitor"
] | false |
ME_TEST_0031 | test | JCP2022_009839 | CCCOc1cc(N)ccc1C(=O)OCCN(CC)CC | InChI=1S/C16H26N2O3/c1-4-10-20-15-12-13(17)7-8-14(15)16(19)21-11-9-18(5-2)6-3/h7-8,12H,4-6,9-11,17H2,1-3H3 | CAJIGINSTLKQMM-UHFFFAOYSA-N | local anesthetic | [
"local anesthetic"
] | local anesthetic | [
"local anesthetic"
] | false |
ME_TEST_0032 | test | JCP2022_010573 | COc1cc(OC)c(NC(=O)N=c2cc(C)o[nH]2)cc1Cl | InChI=1S/C13H14ClN3O4/c1-7-4-12(17-21-7)16-13(18)15-9-5-8(14)10(19-2)6-11(9)20-3/h4-6H,1-3H3,(H2,15,16,17,18) | CEIIEALEIHQDBX-UHFFFAOYSA-N | acetylcholine receptor agonist | [
"acetylcholine receptor agonist"
] | acetylcholine receptor agonist | [
"acetylcholine receptor agonist"
] | false |
ME_TEST_0033 | test | JCP2022_010954 | COc1ccc2c(c1)c(CC(=O)O)c(C)n2C(=O)c1ccc(Cl)cc1 | InChI=1S/C19H16ClNO4/c1-11-15(10-18(22)23)16-9-14(25-2)7-8-17(16)21(11)19(24)12-3-5-13(20)6-4-12/h3-9H,10H2,1-2H3,(H,22,23) | CGIGDMFJXJATDK-UHFFFAOYSA-N | cyclooxygenase inhibitor | [
"cyclooxygenase inhibitor"
] | cyclooxygenase inhibitor | [
"cyclooxygenase inhibitor"
] | false |
ME_TEST_0034 | test | JCP2022_011141 | O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O | InChI=1S/C15H8ClF6NO2/c16-9-1-2-12(24)11(6-9)13(25)23-10-4-7(14(17,18)19)3-8(5-10)15(20,21)22/h1-6,24H,(H,23,25) | CHILCFMQWMQVAL-UHFFFAOYSA-N | IKK inhibitor | [
"IKK inhibitor",
"NFkB pathway inhibitor"
] | IKK inhibitor | [
"IKK inhibitor",
"NFkB pathway inhibitor"
] | false |
ME_TEST_0035 | test | JCP2022_011674 | CCCCCc1ccc(C)cc1O | InChI=1S/C12H18O/c1-3-4-5-6-11-8-7-10(2)9-12(11)13/h7-9,13H,3-6H2,1-2H3 | CKGWFZQGEQJZIL-UHFFFAOYSA-N | sodium channel blocker | [
"sodium channel blocker"
] | sodium channel blocker | [
"sodium channel blocker"
] | false |
ME_TEST_0036 | test | JCP2022_011917 | Cc1c(Cl)cccc1N=c1[nH]cccc1C(=O)O | InChI=1S/C13H11ClN2O2/c1-8-10(14)5-2-6-11(8)16-12-9(13(17)18)4-3-7-15-12/h2-7H,1H3,(H,15,16)(H,17,18) | CLOMYZFHNHFSIQ-UHFFFAOYSA-N | cyclooxygenase inhibitor | [
"cyclooxygenase inhibitor"
] | cyclooxygenase inhibitor | [
"cyclooxygenase inhibitor"
] | false |
ME_TEST_0037 | test | JCP2022_012591 | COC(=O)N=c1[nH]c2ccc(C(=O)c3ccc(F)cc3)cc2[nH]1 | InChI=1S/C16H12FN3O3/c1-23-16(22)20-15-18-12-7-4-10(8-13(12)19-15)14(21)9-2-5-11(17)6-3-9/h2-8H,1H3,(H2,18,19,20,22) | CPEUVMUXAHMANV-UHFFFAOYSA-N | tubulin polymerization inhibitor | [
"tubulin polymerization inhibitor"
] | tubulin polymerization inhibitor | [
"tubulin polymerization inhibitor"
] | false |
ME_TEST_0038 | test | JCP2022_012638 | CCOc1ccc(NC(C)=O)cc1 | InChI=1S/C10H13NO2/c1-3-13-10-6-4-9(5-7-10)11-8(2)12/h4-7H,3H2,1-2H3,(H,11,12) | CPJSUEIXXCENMM-UHFFFAOYSA-N | cyclooxygenase inhibitor | [
"cyclooxygenase inhibitor"
] | cyclooxygenase inhibitor | [
"cyclooxygenase inhibitor"
] | false |
ME_TEST_0039 | test | JCP2022_012711 | CNNCc1ccc(C(=O)NC(C)C)cc1 | InChI=1S/C12H19N3O/c1-9(2)15-12(16)11-6-4-10(5-7-11)8-14-13-3/h4-7,9,13-14H,8H2,1-3H3,(H,15,16) | CPTBDICYNRMXFX-UHFFFAOYSA-N | monoamine oxidase inhibitor | [
"monoamine oxidase inhibitor"
] | monoamine oxidase inhibitor | [
"monoamine oxidase inhibitor"
] | false |
ME_TEST_0040 | test | JCP2022_012905 | C1COC(=NC(C2CC2)C2CC2)N1 | InChI=1S/C10H16N2O/c1-2-7(1)9(8-3-4-8)12-10-11-5-6-13-10/h7-9H,1-6H2,(H,11,12) | CQXADFVORZEARL-UHFFFAOYSA-N | adrenergic receptor agonist | [
"adrenergic receptor agonist",
"imidazoline receptor agonist"
] | adrenergic receptor agonist | [
"adrenergic receptor agonist"
] | false |
ME_TEST_0041 | test | JCP2022_013346 | NC(=O)N1c2ccccc2CC(=O)c2ccccc21 | InChI=1S/C15H12N2O2/c16-15(19)17-12-7-3-1-5-10(12)9-14(18)11-6-2-4-8-13(11)17/h1-8H,9H2,(H2,16,19) | CTRLABGOLIVAIY-UHFFFAOYSA-N | sodium channel blocker | [
"sodium channel blocker"
] | sodium channel blocker | [
"sodium channel blocker"
] | false |
ME_TEST_0042 | test | JCP2022_013525 | N=C(N)N=C(N)Nc1ccccc1 | InChI=1S/C8H11N5/c9-7(10)13-8(11)12-6-4-2-1-3-5-6/h1-5H,(H6,9,10,11,12,13) | CUQCMXFWIMOWRP-UHFFFAOYSA-N | serotonin receptor agonist | [
"serotonin receptor agonist"
] | serotonin receptor agonist | [
"serotonin receptor agonist"
] | false |
ME_TEST_0043 | test | JCP2022_013773 | CNC(=O)Oc1cccc2ccccc12 | InChI=1S/C12H11NO2/c1-13-12(14)15-11-8-4-6-9-5-2-3-7-10(9)11/h2-8H,1H3,(H,13,14) | CVXBEEMKQHEXEN-UHFFFAOYSA-N | acetylcholinesterase inhibitor | [
"acetylcholinesterase inhibitor"
] | acetylcholinesterase inhibitor | [
"acetylcholinesterase inhibitor"
] | false |
ME_TEST_0044 | test | JCP2022_013874 | COc1ccccc1OC(=O)CNC(=O)Cc1ccc(C(=O)c2ccc(C)cc2)n1C | InChI=1S/C24H24N2O5/c1-16-8-10-17(11-9-16)24(29)19-13-12-18(26(19)2)14-22(27)25-15-23(28)31-21-7-5-4-6-20(21)30-3/h4-13H,14-15H2,1-3H3,(H,25,27) | CWJNMKKMGIAGDK-UHFFFAOYSA-N | cyclooxygenase inhibitor | [
"cyclooxygenase inhibitor"
] | cyclooxygenase inhibitor | [
"cyclooxygenase inhibitor"
] | false |
ME_TEST_0045 | test | JCP2022_014282 | Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21 | InChI=1S/C17H15BrClFN4O3/c1-24-8-21-16-13(24)7-10(17(26)23-27-5-4-25)15(14(16)20)22-12-3-2-9(18)6-11(12)19/h2-3,6-8,22,25H,4-5H2,1H3,(H,23,26) | CYOHGALHFOKKQC-UHFFFAOYSA-N | MEK inhibitor | [
"MEK inhibitor"
] | MEK inhibitor | [
"MEK inhibitor"
] | false |
ME_TEST_0046 | test | JCP2022_014569 | CCCN=c1ccc2ncc(-c3ccc4[nH]ncc4c3)n2[nH]1 | InChI=1S/C16H16N6/c1-2-7-17-15-5-6-16-18-10-14(22(16)21-15)11-3-4-13-12(8-11)9-19-20-13/h3-6,8-10H,2,7H2,1H3,(H,17,21)(H,19,20) | CZZCAOGIEGXMBZ-UHFFFAOYSA-N | serine/threonine kinase inhibitor | [
"serine/threonine kinase inhibitor"
] | serine/threonine kinase inhibitor | [
"serine/threonine kinase inhibitor"
] | false |
ME_TEST_0047 | test | JCP2022_015081 | COc1ccc(OC)c(CN(C(C)=O)c2cc(F)ccc2Oc2ccccc2)c1 | InChI=1S/C23H22FNO4/c1-16(26)25(15-17-13-20(27-2)10-12-22(17)28-3)21-14-18(24)9-11-23(21)29-19-7-5-4-6-8-19/h4-14H,15H2,1-3H3 | DCRZYADKQRHHSF-UHFFFAOYSA-N | benzodiazepine receptor agonist | [
"benzodiazepine receptor agonist"
] | benzodiazepine receptor agonist | [
"benzodiazepine receptor agonist"
] | false |
ME_TEST_0048 | test | JCP2022_015262 | COc1cc(N2CCN(C)CC2)ccc1N=c1nc2c(c[nH]1)N(C)C(=O)c1ccccc1N2C | InChI=1S/C25H29N7O2/c1-29-11-13-32(14-12-29)17-9-10-19(22(15-17)34-4)27-25-26-16-21-23(28-25)30(2)20-8-6-5-7-18(20)24(33)31(21)3/h5-10,15-16H,11-14H2,1-4H3,(H,26,27,28) | DDTPGANIPBKTNU-UHFFFAOYSA-N | MAP kinase inhibitor | [
"MAP kinase inhibitor"
] | MAP kinase inhibitor | [
"MAP kinase inhibitor"
] | false |
ME_TEST_0049 | test | JCP2022_015566 | CNC(=O)CN1CCC(Oc2cc3c(=Nc4cccc(Cl)c4F)[nH]cnc3cc2OC)CC1 | InChI=1S/C23H25ClFN5O3/c1-26-21(31)12-30-8-6-14(7-9-30)33-20-10-15-18(11-19(20)32-2)27-13-28-23(15)29-17-5-3-4-16(24)22(17)25/h3-5,10-11,13-14H,6-9,12H2,1-2H3,(H,26,31)(H,27,28,29) | DFJSJLGUIXFDJP-UHFFFAOYSA-N | EGFR inhibitor | [
"EGFR inhibitor"
] | EGFR inhibitor | [
"EGFR inhibitor"
] | false |
ME_TEST_0050 | test | JCP2022_015861 | N=c1[nH]c(OCC2CCCCC2)c(N=O)c(=N)[nH]1 | InChI=1S/C11H17N5O2/c12-9-8(16-17)10(15-11(13)14-9)18-6-7-4-2-1-3-5-7/h7H,1-6H2,(H4,12,13,14,15) | DGWXOLHKVGDQLN-UHFFFAOYSA-N | CDK inhibitor | [
"CDK inhibitor"
] | CDK inhibitor | [
"CDK inhibitor"
] | false |
ME_TEST_0051 | test | JCP2022_015954 | NCC(=O)O | InChI=1S/C2H5NO2/c3-1-2(4)5/h1,3H2,(H,4,5) | DHMQDGOQFOQNFH-UHFFFAOYSA-N | glutamate receptor antagonist | [
"glutamate receptor antagonist"
] | glutamate receptor antagonist | [
"glutamate receptor antagonist"
] | false |
ME_TEST_0052 | test | JCP2022_016107 | CC(=O)c1ccc(NS(C)(=O)=O)c(Oc2ccc(F)cc2F)c1 | InChI=1S/C15H13F2NO4S/c1-9(19)10-3-5-13(18-23(2,20)21)15(7-10)22-14-6-4-11(16)8-12(14)17/h3-8,18H,1-2H3 | DIIYLGZNZGPXRR-UHFFFAOYSA-N | cyclooxygenase inhibitor | [
"cyclooxygenase inhibitor"
] | cyclooxygenase inhibitor | [
"cyclooxygenase inhibitor"
] | false |
ME_TEST_0053 | test | JCP2022_016242 | COc1ccc(-c2noc(CC(=O)O)c2-c2ccc(OC)cc2)cc1 | InChI=1S/C19H17NO5/c1-23-14-7-3-12(4-8-14)18-16(11-17(21)22)25-20-19(18)13-5-9-15(24-2)10-6-13/h3-10H,11H2,1-2H3,(H,21,22) | DJEIHHYCDCTAAH-UHFFFAOYSA-N | cyclooxygenase inhibitor | [
"cyclooxygenase inhibitor"
] | cyclooxygenase inhibitor | [
"cyclooxygenase inhibitor"
] | false |
ME_TEST_0054 | test | JCP2022_016537 | COc1cc2ncnc(Oc3cccc(NC(=O)N=c4cc(C(C)(C)C(F)(F)F)o[nH]4)c3)c2cc1OC | InChI=1S/C24H22F3N5O5/c1-23(2,24(25,26)27)19-11-20(32-37-19)31-22(33)30-13-6-5-7-14(8-13)36-21-15-9-17(34-3)18(35-4)10-16(15)28-12-29-21/h5-12H,1-4H3,(H2,30,31,32,33) | DKNUPRMJNUQNHR-UHFFFAOYSA-N | RAF inhibitor | [
"RAF inhibitor"
] | RAF inhibitor | [
"RAF inhibitor"
] | false |
ME_TEST_0055 | test | JCP2022_016538 | NC12CC3CC(CC(C3)C1)C2 | InChI=1S/C10H17N/c11-10-4-7-1-8(5-10)3-9(2-7)6-10/h7-9H,1-6,11H2 | DKNWSYNQZKUICI-UHFFFAOYSA-N | glutamate receptor antagonist | [
"glutamate receptor antagonist"
] | glutamate receptor antagonist | [
"glutamate receptor antagonist"
] | false |
ME_TEST_0056 | test | JCP2022_018019 | Cn1cc(C2=C(c3cn(CCCSC(=N)N)c4ccccc34)C(=O)NC2=O)c2ccccc21 | InChI=1S/C25H23N5O2S/c1-29-13-17(15-7-2-4-9-19(15)29)21-22(24(32)28-23(21)31)18-14-30(11-6-12-33-25(26)27)20-10-5-3-8-16(18)20/h2-5,7-10,13-14H,6,11-12H2,1H3,(H3,26,27)(H,28,31,32) | DSXXEELGXBCYNQ-UHFFFAOYSA-N | PKC inhibitor | [
"PKC inhibitor"
] | PKC inhibitor | [
"PKC inhibitor"
] | false |
ME_TEST_0057 | test | JCP2022_018311 | Cc1cn(-c2cc(NC(=O)c3ccc(C)c(N=c4nc(-c5cnccn5)cc[nH]4)c3)cc(C(F)(F)F)c2)cn1 | InChI=1S/C27H21F3N8O/c1-16-3-4-18(9-23(16)37-26-33-6-5-22(36-26)24-13-31-7-8-32-24)25(39)35-20-10-19(27(28,29)30)11-21(12-20)38-14-17(2)34-15-38/h3-15H,1-2H3,(H,35,39)(H,33,36,37) | DUPWHXBITIZIKZ-UHFFFAOYSA-N | Bcr-Abl kinase inhibitor | [
"Bcr-Abl kinase inhibitor"
] | Bcr-Abl kinase inhibitor | [
"Bcr-Abl kinase inhibitor"
] | false |
ME_TEST_0058 | test | JCP2022_018939 | O=c1c2ccccc2[se]n1-c1ccccc1 | InChI=1S/C13H9NOSe/c15-13-11-8-4-5-9-12(11)16-14(13)10-6-2-1-3-7-10/h1-9H | DYEFUKCXAQOFHX-UHFFFAOYSA-N | cyclooxygenase inhibitor | [
"cyclooxygenase inhibitor",
"glutathione peroxidase agonist",
"H+/K+-ATPase inhibitor",
"nitric oxide synthase inhibitor"
] | cyclooxygenase inhibitor | [
"cyclooxygenase inhibitor",
"nitric oxide synthase inhibitor"
] | false |
ME_TEST_0059 | test | JCP2022_019001 | CC1(COc2ccc3c(c2)ncn3-c2ccc3cccc(N4CCC(N)CC4)c3n2)COC1 | InChI=1S/C26H29N5O2/c1-26(14-32-15-26)16-33-20-6-7-22-21(13-20)28-17-31(22)24-8-5-18-3-2-4-23(25(18)29-24)30-11-9-19(27)10-12-30/h2-8,13,17,19H,9-12,14-16,27H2,1H3 | DYNHJHQFHQTFTP-UHFFFAOYSA-N | PDGFR tyrosine kinase receptor inhibitor | [
"PDGFR tyrosine kinase receptor inhibitor"
] | PDGFR tyrosine kinase receptor inhibitor | [
"PDGFR tyrosine kinase receptor inhibitor"
] | false |
ME_TEST_0060 | test | JCP2022_019144 | Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)ccc2C)n(C)n1 | InChI=1S/C23H23N7O3/c1-13-4-7-16(11-17(13)24-23(32)18-10-14(2)27-29(18)3)33-21-9-8-20-25-19(12-30(20)28-21)26-22(31)15-5-6-15/h4,7-12,15H,5-6H2,1-3H3,(H,24,32)(H,26,31) | DZFZXPPHBWCXPQ-UHFFFAOYSA-N | VEGFR inhibitor | [
"VEGFR inhibitor"
] | VEGFR inhibitor | [
"VEGFR inhibitor"
] | false |
ME_TEST_0061 | test | JCP2022_019911 | O=c1[nH]cnc2[nH]cnc12 | InChI=1S/C5H4N4O/c10-5-3-4(7-1-6-3)8-2-9-5/h1-2H,(H2,6,7,8,9,10) | FDGQSTZJBFJUBT-UHFFFAOYSA-N | PARP inhibitor | [
"PARP inhibitor"
] | PARP inhibitor | [
"PARP inhibitor"
] | false |
ME_TEST_0062 | test | JCP2022_020054 | O=C(CCCN1CCC(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1 | InChI=1S/C22H24FN3O2/c23-17-9-7-16(8-10-17)21(27)6-3-13-25-14-11-18(12-15-25)26-20-5-2-1-4-19(20)24-22(26)28/h1-2,4-5,7-10,18H,3,6,11-15H2,(H,24,28) | FEBOTPHFXYHVPL-UHFFFAOYSA-N | dopamine receptor antagonist | [
"dopamine receptor antagonist"
] | dopamine receptor antagonist | [
"dopamine receptor antagonist"
] | false |
ME_TEST_0063 | test | JCP2022_020062 | N=c1[nH]c2c(ccc3ccccc32)s1 | InChI=1S/C11H8N2S/c12-11-13-10-8-4-2-1-3-7(8)5-6-9(10)14-11/h1-6H,(H2,12,13) | FECQXVPRUCCUIL-UHFFFAOYSA-N | potassium channel activator | [
"potassium channel activator"
] | potassium channel activator | [
"potassium channel activator"
] | false |
ME_TEST_0064 | test | JCP2022_020211 | COc1cc(C(=O)NCc2ccc(OCCN(C)C)cc2)cc(OC)c1OC | InChI=1S/C21H28N2O5/c1-23(2)10-11-28-17-8-6-15(7-9-17)14-22-21(24)16-12-18(25-3)20(27-5)19(13-16)26-4/h6-9,12-13H,10-11,14H2,1-5H3,(H,22,24) | FEZBIKUBAYAZIU-UHFFFAOYSA-N | histamine receptor antagonist | [
"histamine receptor antagonist"
] | histamine receptor antagonist | [
"histamine receptor antagonist"
] | false |
ME_TEST_0065 | test | JCP2022_020398 | CN1CCN(c2nc3ccccc3nc2Cl)CC1 | InChI=1S/C13H15ClN4/c1-17-6-8-18(9-7-17)13-12(14)15-10-4-2-3-5-11(10)16-13/h2-5H,6-9H2,1H3 | FFXVTQDGTKEXHF-UHFFFAOYSA-N | serotonin receptor antagonist | [
"serotonin receptor antagonist"
] | serotonin receptor antagonist | [
"serotonin receptor antagonist"
] | false |
ME_TEST_0066 | test | JCP2022_020544 | O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccnc2ccccc12 | InChI=1S/C22H16F3N3O2S/c23-22(24,25)30-16-7-5-15(6-8-16)28-21(29)20-19(10-12-31-20)27-13-14-9-11-26-18-4-2-1-3-17(14)18/h1-12,27H,13H2,(H,28,29) | FGTCROZDHDSNIO-UHFFFAOYSA-N | KIT inhibitor | [
"KIT inhibitor",
"VEGFR inhibitor"
] | KIT inhibitor | [
"KIT inhibitor",
"VEGFR inhibitor"
] | false |
ME_TEST_0067 | test | JCP2022_020778 | NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCO4)c(-c3ccccn3)[nH]2)cc1 | InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26) | FHYUGAJXYORMHI-UHFFFAOYSA-N | TGF beta receptor inhibitor | [
"TGF beta receptor inhibitor",
"activin receptor inhibitor"
] | TGF beta receptor inhibitor | [
"TGF beta receptor inhibitor"
] | false |
ME_TEST_0068 | test | JCP2022_020984 | Cc1cccc(-c2[nH]c(CNc3ccccc3F)nc2-c2ccc3ncnn3c2)n1 | InChI=1S/C22H18FN7/c1-14-5-4-8-18(27-14)22-21(15-9-10-20-25-13-26-30(20)12-15)28-19(29-22)11-24-17-7-3-2-6-16(17)23/h2-10,12-13,24H,11H2,1H3,(H,28,29) | FJCDSQATIJKQKA-UHFFFAOYSA-N | TGF beta receptor inhibitor | [
"TGF beta receptor inhibitor"
] | TGF beta receptor inhibitor | [
"TGF beta receptor inhibitor"
] | false |
ME_TEST_0069 | test | JCP2022_021051 | CCCN=c1nc(N(C)OC)[nH]c(=NCCC)[nH]1 | InChI=1S/C11H22N6O/c1-5-7-12-9-14-10(13-8-6-2)16-11(15-9)17(3)18-4/h5-8H2,1-4H3,(H2,12,13,14,15,16) | FJNLCHNQVJVCPY-UHFFFAOYSA-N | calcium channel blocker | [
"calcium channel blocker"
] | calcium channel blocker | [
"calcium channel blocker"
] | false |
ME_TEST_0070 | test | JCP2022_021472 | O=c1[nH]c2cc(Cl)ccc2c(O)c1-c1cccc(Oc2ccccc2)c1 | InChI=1S/C21H14ClNO3/c22-14-9-10-17-18(12-14)23-21(25)19(20(17)24)13-5-4-8-16(11-13)26-15-6-2-1-3-7-15/h1-12H,(H2,23,24,25) | FLVRDMUHUXVRET-UHFFFAOYSA-N | glutamate receptor antagonist | [
"glutamate receptor antagonist"
] | glutamate receptor antagonist | [
"glutamate receptor antagonist"
] | false |
ME_TEST_0071 | test | JCP2022_021538 | COc1cc2c3c(n(CCCN4CCOCC4)c(=O)c2cc1OC)-c1cc2c(cc1C3=O)OCO2 | InChI=1S/C26H26N2O7/c1-31-19-10-15-18(13-20(19)32-2)26(30)28(5-3-4-27-6-8-33-9-7-27)24-16-11-21-22(35-14-34-21)12-17(16)25(29)23(15)24/h10-13H,3-9,14H2,1-2H3 | FMFIFGLHVOZDEL-UHFFFAOYSA-N | topoisomerase inhibitor | [
"topoisomerase inhibitor"
] | topoisomerase inhibitor | [
"topoisomerase inhibitor"
] | false |
ME_TEST_0072 | test | JCP2022_021886 | S=P(N1CC1)(N1CC1)N1CC1 | InChI=1S/C6H12N3PS/c11-10(7-1-2-7,8-3-4-8)9-5-6-9/h1-6H2 | FOCVUCIESVLUNU-UHFFFAOYSA-N | cytochrome P450 inhibitor | [
"cytochrome P450 inhibitor"
] | cytochrome P450 inhibitor | [
"cytochrome P450 inhibitor"
] | false |
ME_TEST_0073 | test | JCP2022_022068 | O=C(c1ccc(F)cc1)C1CCN(CCn2c(=O)[nH]c3ccccc3c2=O)CC1 | InChI=1S/C22H22FN3O3/c23-17-7-5-15(6-8-17)20(27)16-9-11-25(12-10-16)13-14-26-21(28)18-3-1-2-4-19(18)24-22(26)29/h1-8,16H,9-14H2,(H,24,29) | FPCCSQOGAWCVBH-UHFFFAOYSA-N | serotonin receptor antagonist | [
"serotonin receptor antagonist"
] | serotonin receptor antagonist | [
"serotonin receptor antagonist"
] | false |
ME_TEST_0074 | test | JCP2022_022505 | O=C(N=c1cc[nH]cc1)c1cc([N+](=O)[O-])ccc1Cl | InChI=1S/C12H8ClN3O3/c13-11-2-1-9(16(18)19)7-10(11)12(17)15-8-3-5-14-6-4-8/h1-7H,(H,14,15,17) | FRPJSHKMZHWJBE-UHFFFAOYSA-N | PPAR receptor antagonist | [
"PPAR receptor antagonist"
] | PPAR receptor antagonist | [
"PPAR receptor antagonist"
] | false |
ME_TEST_0075 | test | JCP2022_022692 | COc1ccc2c(c1)c(CC(=O)OCC(=O)O)c(C)n2C(=O)c1ccc(Cl)cc1 | InChI=1S/C21H18ClNO6/c1-12-16(10-20(26)29-11-19(24)25)17-9-15(28-2)7-8-18(17)23(12)21(27)13-3-5-14(22)6-4-13/h3-9H,10-11H2,1-2H3,(H,24,25) | FSQKKOOTNAMONP-UHFFFAOYSA-N | cyclooxygenase inhibitor | [
"cyclooxygenase inhibitor"
] | cyclooxygenase inhibitor | [
"cyclooxygenase inhibitor"
] | false |
ME_TEST_0076 | test | JCP2022_022792 | CN1CCC(N=c2nc3c(=Nc4ccc(F)c(Cl)c4)[nH]cnc3c[nH]2)CC1 | InChI=1S/C18H19ClFN7/c1-27-6-4-11(5-7-27)25-18-21-9-15-16(26-18)17(23-10-22-15)24-12-2-3-14(20)13(19)8-12/h2-3,8-11H,4-7H2,1H3,(H,21,25,26)(H,22,23,24) | FTFRZXFNZVCRSK-UHFFFAOYSA-N | EGFR inhibitor | [
"EGFR inhibitor"
] | EGFR inhibitor | [
"EGFR inhibitor"
] | false |
ME_TEST_0077 | test | JCP2022_022963 | CCOC(=O)Nc1ccc2c(c1)N(C(=O)CCN1CCOCC1)c1ccccc1S2 | InChI=1S/C22H25N3O4S/c1-2-29-22(27)23-16-7-8-20-18(15-16)25(17-5-3-4-6-19(17)30-20)21(26)9-10-24-11-13-28-14-12-24/h3-8,15H,2,9-14H2,1H3,(H,23,27) | FUBVWMNBEHXPSU-UHFFFAOYSA-N | sodium channel blocker | [
"sodium channel blocker"
] | sodium channel blocker | [
"sodium channel blocker"
] | false |
ME_TEST_0078 | test | JCP2022_023274 | COc1ccc(-c2cnc3c(-c4cccc5ncccc45)cnn3c2)cc1 | InChI=1S/C22H16N4O/c1-27-17-9-7-15(8-10-17)16-12-24-22-20(13-25-26(22)14-16)18-4-2-6-21-19(18)5-3-11-23-21/h2-14H,1H3 | FVRYPYDPKSZGNS-UHFFFAOYSA-N | ALK tyrosine kinase receptor inhibitor | [
"ALK tyrosine kinase receptor inhibitor"
] | ALK tyrosine kinase receptor inhibitor | [
"ALK tyrosine kinase receptor inhibitor"
] | false |
ME_TEST_0079 | test | JCP2022_023307 | C=CCc1ccc(O)c(-c2ccc(O)c(CC=C)c2)c1 | InChI=1S/C18H18O2/c1-3-5-13-7-9-18(20)16(11-13)14-8-10-17(19)15(12-14)6-4-2/h3-4,7-12,19-20H,1-2,5-6H2 | FVYXIJYOAGAUQK-UHFFFAOYSA-N | AKT inhibitor | [
"AKT inhibitor"
] | AKT inhibitor | [
"AKT inhibitor"
] | false |
ME_TEST_0080 | test | JCP2022_023826 | Cc1ncc(NC(=O)c2cccc(C(F)(F)F)c2)cc1-c1cnc(OC2CCOCC2)c(N2CCOCC2)c1 | InChI=1S/C28H29F3N4O4/c1-18-24(15-22(17-32-18)34-26(36)19-3-2-4-21(13-19)28(29,30)31)20-14-25(35-7-11-38-12-8-35)27(33-16-20)39-23-5-9-37-10-6-23/h2-4,13-17,23H,5-12H2,1H3,(H,34,36) | FYNMINFUAIDIFL-UHFFFAOYSA-N | RAF inhibitor | [
"RAF inhibitor"
] | RAF inhibitor | [
"RAF inhibitor"
] | false |
ME_TEST_0081 | test | JCP2022_024642 | COc1cc(N2CCC(N)CC2)ccc1N=c1nc(-c2c[nH]c3ccccc23)c(Cl)c[nH]1 | InChI=1S/C24H25ClN6O/c1-32-22-12-16(31-10-8-15(26)9-11-31)6-7-21(22)29-24-28-14-19(25)23(30-24)18-13-27-20-5-3-2-4-17(18)20/h2-7,12-15,27H,8-11,26H2,1H3,(H,28,29,30) | GCYIGMXOIWJGBU-UHFFFAOYSA-N | ALK tyrosine kinase receptor inhibitor | [
"ALK tyrosine kinase receptor inhibitor",
"insulin growth factor receptor inhibitor"
] | ALK tyrosine kinase receptor inhibitor | [
"ALK tyrosine kinase receptor inhibitor",
"insulin growth factor receptor inhibitor"
] | false |
ME_TEST_0082 | test | JCP2022_024747 | CC1=NS(=O)(=O)c2cc(Cl)ccc2N1 | InChI=1S/C8H7ClN2O2S/c1-5-10-7-3-2-6(9)4-8(7)14(12,13)11-5/h2-4H,1H3,(H,10,11) | GDLBFKVLRPITMI-UHFFFAOYSA-N | potassium channel activator | [
"potassium channel activator"
] | potassium channel activator | [
"potassium channel activator"
] | false |
ME_TEST_0083 | test | JCP2022_024803 | CCCNC(=O)c1cn2[nH]cnc(=Nc3cc(C(=O)NC4CC4)ccc3C)c2c1C | InChI=1S/C22H26N6O2/c1-4-9-23-22(30)17-11-28-19(14(17)3)20(24-12-25-28)27-18-10-15(6-5-13(18)2)21(29)26-16-7-8-16/h5-6,10-12,16H,4,7-9H2,1-3H3,(H,23,30)(H,26,29)(H,24,25,27) | GDTQLZHHDRRBEB-UHFFFAOYSA-N | p38 MAPK inhibitor | [
"p38 MAPK inhibitor"
] | p38 MAPK inhibitor | [
"p38 MAPK inhibitor"
] | false |
ME_TEST_0084 | test | JCP2022_025145 | O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl | InChI=1S/C17H14ClF2IN2O2/c18-12-7-10(21)3-6-14(12)22-16-11(4-5-13(19)15(16)20)17(24)23-25-8-9-1-2-9/h3-7,9,22H,1-2,8H2,(H,23,24) | GFMMXOIFOQCCGU-UHFFFAOYSA-N | MEK inhibitor | [
"MEK inhibitor"
] | MEK inhibitor | [
"MEK inhibitor"
] | false |
ME_TEST_0085 | test | JCP2022_025157 | COc1cc2[nH]cnc(=Nc3cccc(Cl)c3)c2cc1OC | InChI=1S/C16H14ClN3O2/c1-21-14-7-12-13(8-15(14)22-2)18-9-19-16(12)20-11-5-3-4-10(17)6-11/h3-9H,1-2H3,(H,18,19,20) | GFNNBHLJANVSQV-UHFFFAOYSA-N | EGFR inhibitor | [
"EGFR inhibitor"
] | EGFR inhibitor | [
"EGFR inhibitor"
] | false |
ME_TEST_0086 | test | JCP2022_025492 | Oc1cccc(O)c1 | InChI=1S/C6H6O2/c7-5-2-1-3-6(8)4-5/h1-4,7-8H | GHMLBKRAJCXXBS-UHFFFAOYSA-N | phosphodiesterase inhibitor | [
"phosphodiesterase inhibitor"
] | phosphodiesterase inhibitor | [
"phosphodiesterase inhibitor"
] | false |
ME_TEST_0087 | test | JCP2022_025574 | N=C(N=C(N)NCCCCCCN=C(N)N=C(N)Nc1ccc(Cl)cc1)Nc1ccc(Cl)cc1 | InChI=1S/C22H30Cl2N10/c23-15-5-9-17(10-6-15)31-21(27)33-19(25)29-13-3-1-2-4-14-30-20(26)34-22(28)32-18-11-7-16(24)8-12-18/h5-12H,1-4,13-14H2,(H5,25,27,29,31,33)(H5,26,28,30,32,34) | GHXZTYHSJHQHIJ-UHFFFAOYSA-N | membrane integrity inhibitor | [
"membrane integrity inhibitor"
] | membrane integrity inhibitor | [
"membrane integrity inhibitor"
] | false |
ME_TEST_0088 | test | JCP2022_025645 | COc1ccc(CNCc2cccc3ccccc23)cc1 | InChI=1S/C19H19NO/c1-21-18-11-9-15(10-12-18)13-20-14-17-7-4-6-16-5-2-3-8-19(16)17/h2-12,20H,13-14H2,1H3 | GIFYKGIODMXYNT-UHFFFAOYSA-N | potassium channel blocker | [
"potassium channel blocker"
] | potassium channel blocker | [
"potassium channel blocker"
] | false |
ME_TEST_0089 | test | JCP2022_025690 | Cc1nc(-c2csc(=NC(=N)N)[nH]2)c[nH]1 | InChI=1S/C8H10N6S/c1-4-11-2-5(12-4)6-3-15-8(13-6)14-7(9)10/h2-3H,1H3,(H,11,12)(H4,9,10,13,14) | GIMNAEMRNXUAQP-UHFFFAOYSA-N | histamine receptor antagonist | [
"histamine receptor antagonist"
] | histamine receptor antagonist | [
"histamine receptor antagonist"
] | false |
ME_TEST_0090 | test | JCP2022_025798 | CCN(CC)CCNC(=O)c1cc(Br)c(N)cc1OC | InChI=1S/C14H22BrN3O2/c1-4-18(5-2)7-6-17-14(19)10-8-11(15)12(16)9-13(10)20-3/h8-9H,4-7,16H2,1-3H3,(H,17,19) | GIYAQDDTCWHPPL-UHFFFAOYSA-N | dopamine receptor antagonist | [
"dopamine receptor antagonist"
] | dopamine receptor antagonist | [
"dopamine receptor antagonist"
] | false |
ME_TEST_0091 | test | JCP2022_026032 | O=C(Nc1ccc2[nH]c(=O)oc2c1)C(=O)N1CCC(Cc2ccc(F)cc2)CC1 | InChI=1S/C21H20FN3O4/c22-15-3-1-13(2-4-15)11-14-7-9-25(10-8-14)20(27)19(26)23-16-5-6-17-18(12-16)29-21(28)24-17/h1-6,12,14H,7-11H2,(H,23,26)(H,24,28) | GKGRZLGAQZPEHO-UHFFFAOYSA-N | acetylcholine receptor antagonist | [
"acetylcholine receptor antagonist"
] | acetylcholine receptor antagonist | [
"acetylcholine receptor antagonist"
] | false |
ME_TEST_0092 | test | JCP2022_026193 | COc1ccc2c(Oc3ccc(=NC(=O)c4c(C)n(CC(C)(C)O)n(-c5ccccc5)c4=O)[nH]c3)ccnc2c1 | InChI=1S/C30H29N5O5/c1-19-27(29(37)35(20-8-6-5-7-9-20)34(19)18-30(2,3)38)28(36)33-26-13-11-22(17-32-26)40-25-14-15-31-24-16-21(39-4)10-12-23(24)25/h5-17,38H,18H2,1-4H3,(H,32,33,36) | GLBZSOQDAOLMGC-UHFFFAOYSA-N | MET inhibitor | [
"MET inhibitor"
] | MET inhibitor | [
"MET inhibitor"
] | false |
ME_TEST_0093 | test | JCP2022_026329 | C1CNCCN1 | InChI=1S/C4H10N2/c1-2-6-4-3-5-1/h5-6H,1-4H2 | GLUUGHFHXGJENI-UHFFFAOYSA-N | benzodiazepine receptor agonist | [
"benzodiazepine receptor agonist"
] | benzodiazepine receptor agonist | [
"benzodiazepine receptor agonist"
] | false |
ME_TEST_0094 | test | JCP2022_026424 | N=c1[nH]cnc2c1c(-c1ccc(Oc3ccccc3)cc1)nn2C1CCCC1 | InChI=1S/C22H21N5O/c23-21-19-20(26-27(16-6-4-5-7-16)22(19)25-14-24-21)15-10-12-18(13-11-15)28-17-8-2-1-3-9-17/h1-3,8-14,16H,4-7H2,(H2,23,24,25) | GMJUPMONHWAZCP-UHFFFAOYSA-N | Bruton's tyrosine kinase (BTK) inhibitor | [
"Bruton's tyrosine kinase (BTK) inhibitor"
] | Bruton's tyrosine kinase (BTK) inhibitor | [
"Bruton's tyrosine kinase (BTK) inhibitor"
] | false |
ME_TEST_0095 | test | JCP2022_026507 | Clc1cccc(-n2[nH]nnc2=NCc2ccccc2Oc2ccccn2)c1Cl | InChI=1S/C19H14Cl2N6O/c20-14-7-5-8-15(18(14)21)27-19(24-25-26-27)23-12-13-6-1-2-9-16(13)28-17-10-3-4-11-22-17/h1-11H,12H2,(H,23,24,26) | GMVNBKZQJFRFAR-UHFFFAOYSA-N | purinergic receptor antagonist | [
"purinergic receptor antagonist"
] | purinergic receptor antagonist | [
"purinergic receptor antagonist"
] | false |
ME_TEST_0096 | test | JCP2022_026533 | NC(=O)CN1CCCC1=O | InChI=1S/C6H10N2O2/c7-5(9)4-8-3-1-2-6(8)10/h1-4H2,(H2,7,9) | GMZVRMREEHBGGF-UHFFFAOYSA-N | acetylcholine receptor agonist | [
"acetylcholine receptor agonist"
] | acetylcholine receptor agonist | [
"acetylcholine receptor agonist"
] | false |
ME_TEST_0097 | test | JCP2022_026750 | Cc1nc(C#Cc2ccnc(Cl)c2)c(C)n1-c1ccc(OC(F)(F)F)cc1 | InChI=1S/C19H13ClF3N3O/c1-12-17(8-3-14-9-10-24-18(20)11-14)25-13(2)26(12)15-4-6-16(7-5-15)27-19(21,22)23/h4-7,9-11H,1-2H3 | GOHCTCOGYKAJLZ-UHFFFAOYSA-N | glutamate receptor antagonist | [
"glutamate receptor antagonist"
] | glutamate receptor antagonist | [
"glutamate receptor antagonist"
] | false |
ME_TEST_0098 | test | JCP2022_026859 | CN1CCc2c(c3ccccc3n2Cc2ccc(C(O)=NO)cc2)C1 | InChI=1S/C20H21N3O2/c1-22-11-10-19-17(13-22)16-4-2-3-5-18(16)23(19)12-14-6-8-15(9-7-14)20(24)21-25/h2-9,25H,10-13H2,1H3,(H,21,24) | GOVYBPLHWIEHEJ-UHFFFAOYSA-N | HDAC inhibitor | [
"HDAC inhibitor"
] | HDAC inhibitor | [
"HDAC inhibitor"
] | false |
ME_TEST_0099 | test | JCP2022_028072 | CN1CCC2=C(C1)c1ccccc1Cc1ccccc12 | InChI=1S/C19H19N/c1-20-11-10-18-16-8-4-2-6-14(16)12-15-7-3-5-9-17(15)19(18)13-20/h2-9H,10-13H2,1H3 | GVPIXRLYKVFFMK-UHFFFAOYSA-N | adrenergic receptor antagonist | [
"adrenergic receptor antagonist"
] | adrenergic receptor antagonist | [
"adrenergic receptor antagonist"
] | false |
ME_TEST_0100 | test | JCP2022_028551 | CC(C)n1nc(-c2ccc3oc(=N)[nH]c3c2)c2c(=N)[nH]cnc21 | InChI=1S/C15H15N7O/c1-7(2)22-14-11(13(16)18-6-19-14)12(21-22)8-3-4-10-9(5-8)20-15(17)23-10/h3-7H,1-2H3,(H2,17,20)(H2,16,18,19) | GYLDXIAOMVERTK-UHFFFAOYSA-N | mTOR inhibitor | [
"mTOR inhibitor"
] | mTOR inhibitor | [
"mTOR inhibitor"
] | false |
YAML Metadata Warning:empty or missing yaml metadata in repo card
Check out the documentation for more information.
PhenoAIR MoA Benchmark Data
This directory contains three mechanism-of-action benchmark tracks:
| Track | Reference compounds | Test compounds | Task |
|---|---|---|---|
moa_verified |
63 | 200 | MoA prediction in the verified label space |
moa_extended |
533 | 600 | MoA prediction in the extended label space |
moa_novel |
63 | 100 | Joint known-MoA prediction and novel-MoA detection |
The release contains dataset records and phenotype features only. It does not contain model predictions, agent trajectories, prompts, controller rules, or experiment logs.
Layout
Each track is self-contained:
<track>/
├── reference.parquet
├── test.parquet
├── labels.json
└── features/
├── cellprofiler_features.npy
├── cellprofiler_index.parquet
├── cellprofiler_feature_names.json
├── cellclip_features.npy
├── cellclip_index.parquet
└── feature_manifest.json
dataset_manifest.json describes the release-level schema and row counts.
checksums.sha256 provides SHA-256 checksums for all release files.
Compound Tables
reference.parquet and test.parquet use the following columns:
| Column | Type | Description |
|---|---|---|
sample_id |
string | Stable row identifier within a benchmark track |
split |
string | reference or test |
compound_id |
string | JUMP-CP compound identifier |
smiles |
string | Compound SMILES |
inchi |
string | Compound InChI |
inchikey |
string | Compound InChIKey |
primary_moa |
string | Primary biological MoA annotation |
valid_moas |
list[string] | All valid biological MoA annotations |
benchmark_label |
string | Label used for exact-match evaluation |
benchmark_valid_labels |
list[string] | Labels accepted for any-match evaluation |
is_novel |
bool | Whether the compound is outside the known reference label space |
Compound names and target annotations are omitted from the benchmark tables to reduce direct knowledge leakage.
For moa_novel, benchmark_label is novel moa when is_novel is true.
primary_moa and valid_moas retain the biological annotations for downstream
error analysis.
Phenotype Features
Every *_features.npy file is a two-dimensional float32 array. Row i in a
matrix corresponds exactly to row i in its *_index.parquet file, as recorded
by the row_index column.
CellProfiler features are well-level, harmonized JUMP-CP profiles with variance,
MAD, and intensity feature filtering. Their column names are stored in
cellprofiler_feature_names.json.
CellCLIP features are 768-dimensional well-level embeddings. They were plate-normalized using negative-control median/MAD statistics and globally whitened using negative-control profiles.
The feature index tables contain:
row_indexprofile_idcompound_idsplitsourceplatewell- CellCLIP-only acquisition metadata when available
Load a matrix and its aligned metadata with:
import numpy as np
import pandas as pd
features = np.load("moa_verified/features/cellclip_features.npy", mmap_mode="r")
index = pd.read_parquet("moa_verified/features/cellclip_index.parquet")
assert features.shape[0] == len(index)
Labels
Each labels.json distinguishes the primary reference-label space from the
larger set of all valid annotations. Label strings are case-sensitive. The
special label for out-of-reference compounds is exactly novel moa.
Citation
If you use this dataset, please cite:
@inproceedings{chen2026phenoair,
title = {From Retrieval to Reasoning: Agentic Mechanism Prediction from Cell Painting Profiles},
author = {Chen, Jiayuan and Yu, Botao and Liu, Tianyu and Pham, Thai-Hoang and Wu, Meng and Zhang, Ping},
booktitle = {Advances in Neural Information Processing Systems},
year = {2026}
}
- Downloads last month
- 532